Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.02 |
---|---|
High | 2.02 |
Low | 1.92 |
Bid | 1.97 |
Offer | 2.00 |
Previous close | 2.01 |
Average volume | 405.43k |
---|---|
Shares outstanding | 37.46m |
Free float | 26.69m |
P/E (TTM) | -- |
Market cap | 75.30m USD |
EPS (TTM) | -2.53 USD |
Data delayed at least 15 minutes, as of Oct 09 2024 18:07 BST.
More ▼
Announcements
- Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
- Metagenomi Announces Preclinical Data for Lead Hemophilia A Program Demonstrating Durable Factor VIII (FVIII) Activity Levels through Twelve Months
- Metagenomi Presents AI-Enabled Advancements of SMART Editing Platform at the Cold Spring Harbor Laboratory CRISPR Frontiers Conference
- Metagenomi to Participate in Upcoming Investor Conferences
- Metagenomi Reports Business Updates and Second Quarter 2024 Financial Results
- Metagenomi to Present at the 2024 Jefferies Global Healthcare Conference
- Metagenomi Presents Data at Scientific Conferences and First Quarter 2024 Financial Results
- Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems
- Metagenomi to Present at Upcoming Scientific Meetings
- Metagenomi Reports Business Updates and Full Year 2023 Financial Results
More ▼